Adrenomedullin: A Vasoactive and Natriuretic Peptide with Therapeutic Potential

Heart Disease

Volumn 2, Issue 3, 2000, Pages 259-265

  Lah, John J ^a   Frishman, William H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ATRIAL NATRIURETIC FACTOR; PEPTIDE; VASODILATOR AGENT;

CARDIOVASCULAR DISEASE; DRUG EFFECT; HEMODYNAMICS; HUMAN; PATHOPHYSIOLOGY; REVIEW;

ATRIAL NATRIURETIC FACTOR; CARDIOVASCULAR DISEASES; HEMODYNAMICS; HUMAN; PEPTIDES; VASODILATOR AGENTS;

EID: 0034189590     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto F. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophvs Res Commun 1993;192(2):553-560.
2. Kitamura K, Kangawa K, Matsuo H, Eto T. Adrenomedullin: implications for hypertension research. Drugs 1995;49:485-495.
3. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 1993;194(2):720-725.
4. Kitamura K, Kangawa K, Kojima M, Ichiki Y, Matsuo H, Eto T. Complete amino acid sequence of porcine adrenomedullin and cloning of cDNA encoding its precursor. FEBS Lett 1994;338:306-310.
5. Ishimitsu T, Kojima M, Kangawa K, Hino J, Matsuoka H, Kitamura K, et al. Genomic structure of human adrenomedullin gene. Biochem Biophys Res Commun 1994;203(1):631-639.
6. Samson WK, Murphy TC, Resch ZT. Proadrenomedullin N-terminal 20 peptide inhibits adrenocorticotropin secretion from cultured pituitary cells, possibly via activation of a potassium channel. Endocrine 1998;9(3):269-272.
7. Samson WK. Adrenomedullin and the control of fluid and electrolyte homeostasis. Annu Rev Physiol 1999;61:363-389.
8. Samson WK. Proadrenomedullin-derived peptides. Front Neuroendocrinol 1998;19(2):100-127.
9. Samson WK, Bode AM, Murphy TC, Resch ZT. Antisense oligonucleotide treatment reveals a physiologically relevant role for adrenomedullin gene products in sodium intake. Brain Res 1999;818(1):164-167.
10. Sato K, Hirata Y, Imai T, Iwashita M, Mariuo F. Characterization of immuno-reactive adrenomedullin in human plasma and urine. Life Sci 1995;57(2):189-194.
11. Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994;201(3):1160-1166.
12. Nishikimi T, Kitamura K, Saito Y, Shimada K, Ishimitsu T, Takamiya M, et al. Clinical studies on the sites for circulating adrenomedullin in human subjects. Hypertension 1994;24(5):600-604.
13. 2+ dependent cosecretion of adrenomedullin and catecholamines mediated by nicotinic receptors in bovine cultured adrenal medullary cells. FEBS Lett 1994; 348(1):61-64.
14. Ishizaka Y, Tanaka M, Kitamura K, Kangawa K, Minamino N, Matsuo H, Eto T. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1994;200(1):642-646.
15. Eguchi S, Hirata Y, Kano H, Sato K, Watanabe Y, Watanabe TX, et al. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett 1994;340(3):226-230.
16. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsuo H. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor. Biochem Biophys Res Commun 1994;203(1):719-726.
17. Minamino, N, Shoji H, Sugo S, Kangawa K, Matsuo H. Adrenocortical steroids, thyroid hormones and retinoic acid augment the production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 1995;211(2): 686-693.
18. Leitman DC, Ribeiro RC, Mackow ER, Baxter JD, West BL. Identification of a tumor necrosis factor-responsive element in the tumor necrosis factor alpha gene. J Biol Chem 1991;266(15):9343-9346.
19. Shin HS, Drysdale BE, Shin ML, Noble PW, Fisher SN, Paznckas WA. Definition of a lipopolysaccharide-responsive element in the 5′-flanking regions of MuRantes and Crg-2. Mol Cell Biol 1994;14(5):2914-2925.
20. Ucda S, Nishio K, Minamino N, Kubo A, Akai Y, Kangawa K, et al. Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am J Respir Crit Care Med 1999;160(1):132-136.
21. Brain S, Williams TJ, Tippins JR, Morris HR, MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature 1985;313(5997):54-56.
22. Barber DA, Park YS, Burnett JC Jr, Miller VM. Adrenomedullin-mediated relaxations in veins are endothelium-dependent and distinct from arteries. J Cardiovasc Pharmacol 1997;30(5):695-701.
23. Horio T, Kohno M, Kano H, Ikeda M, Yasunari K, Yokokawa K, et al. Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ Res 1995;77(4):660-664.
24. Kohno M, Kano H, Horio T, Yokokawa K, Yasunari K, Takeda T. Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells. Hypertension 1995;25(6):1185-1190.
25. Kohno M, Yasunari K, Yokokawa K, Horio T, Ikeda M, Kano H, et al. Interaction of adrenomedullin and platelet-derived growth factor on rat mesangial cell production of endothelin. Hypertension 1996;27(3 pt 2):663-667.
26. Chini EN, Choi E, Grande JP, Burnett JC, Dousa TP. Adrenomedullin suppresses mitogenesis in rat mesangial cells via cAMP pathway. Biochem Biophys Res Commun 1995;215(3):868-873.
27. Fukuhara M, Tsuchihashi T, Abe I, Fujishima M. Cardiovascular and neurohor monal effects of intravenous adrenomedullin in conscious rabbits. Am J Physiol 1995;269(5 pt 2):R1289-1293.
28. Matsumura K, Abe I, Tsuchihashi T, Fujishima M. Central adrenomedullin augments the baroreceptor reflex in conscious rabbits. Hypertension 1999;33(4):992-997.
29. Entzeroth M, Doods HN, Wieland HA, Wiene W. Adrenomedullin mediates vasodilation via CGRP1 receptors. Life Sci 1995;56(1):PL19-25.
30. 2+ mobilization in bovine aortic endothelial cells. J Biol Chem 1995;270(9):4412-4417.
31. Samson WK, Murphy TC, Resch ZT. Central mechanisms for the hypertensive effects of preproadrenomedullin-derived peptides in conscious rats. Am J Physiol 1998;274(5 pt 2):R1505-1509.
32. Feng CJ, Kang B, Kaye AD, Kadowitz PJ, Nossaman BD. L-NAME modulates responses to adrenomedullin in the hindquarters vascular bed of the rat. Life Sci 1994;55(22):PL433-438.
33. Ishiyama Y, Kitamura K, Ichiki Y, Nakamura S, Kida O, Kangawa K, Eto T. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol 1993;241(2-3):271-273.
34. Rössler A, László Z, Haditsch B, Hinghofer-Szalkay HG. Orthostatic stimuli rapidly change plasma adrenomedullin in humans. Hypertension 1999; 34:1147-1151.
35. Sakata J, Shimokubo T, Kitamura K, Nakamura S, Kangawa K, Matsuo H, Eto T. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Commun 1993;195(2):921-927.
36. Parkes DG, May CN. ACTH-suppressive and vasodilator actions of adrenomedullin in conscious sheep. J Neuroendocrinol 1995;7(12):923-929.
37. Samson WK, Murphy T, Schell DA. A novel vasoactivc peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release. Endocrinology 1995;136(5): 2349-2352.
38. Meeran K, O'Shea D, Upton PD, Small CJ, Ghatei MA, Byfield PH, Bloom SR. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J Clin Endocrinol Metab 1997;82(1):95-100.
39. Charles CJ, Lainchbury JG, Lewis LK, Rademaker MT, Richards AM, Yandle TG, Nicholls G. The role of adrenomedullin. Am J Hypertens 1999;12(2 Part 1):166-173.
40. Jougasaki M, Wei C, Aarhus LL, Heublein DM, Sandberg SM, Burnett JC Jr. Renal localization and actions of adrenomedullin: a natriuretic peptide. Am J Physiol 1995;268(4 Part 2):F657-663.
41. Samson WK, Murphy TC. Adrenomedullin inhibits salt appetite. Endocrinology 1997;138(2):613-616.
42. Lainchbury JG, Cooper GJS, Coy DH, Jiang NY, Lewis LK, Yandle TG, et al. Adrenomedullin: a hypotensive hormone in man. Clin Sci 1997;92(5):467-472.
43. Yamaguchi T, Baba K, Doi Y, Yano K. Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells. Life Sci 1995;56(6): 379-387.
44. Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K, et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide in patients with hypertension and renal failure. J Clin Invest 1994;94(5):2158-2161.
45. Morimoto A, Nishikimi T, Yoshihara F, Horio T, Nagaya N, Matsuo H, et al. Ventricular adrenomedullin levels correlate with the extent of cardiac hypertrophy in rats. Hypertension 1999;33:1146-1152.
46. Kamiya H, Okumura K, Sone T, Tsuboi H, Kondo J, Mukawa H, et al. Plasma adrenomedullin levels in the coronary circulation in vasoplastic angina pectoris. Am J Cardiol 2000;85:656-657.
47. Yamaji T, Ishibashi M, Takaku F. Atrial natriuretic factor in human blood. J Clin Invest 1985;76(4):1705-1709.
48. Hirata Y, Ishii M, Fukui K, Hayakawa H, Namba S, Dan Y, et al. A possible physiological role of atrial natriuretic factor in body fluid volume regulation. J Cardiovasc Pharmacol 1989;13(Suppl 6):S63-68.
49. Kato J, Kitamura K, Kuwasako K, Tanaka M, Ishiyama Y, Shimokubo T, et al. Plasma adrenomedullin patients with primary aldosteronism. Am J Hypertens 1995;8(10 Part 1):997-1000.
50. Yoshihara F, Nishikimi T, Horio T, Yutani C, Takishita S, Matsuo H, et al. Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline. Eur J Pharmacol 1998;355(1):33-39.
51. Yang BC, Lippton H, Gumusel B, Hyman A, Mehta JL. Adrenomedullin dilates rat pulmonary artery rings during hypoxia: role of nitric oxide and vasodilator prostaglandins. J Cardiovasc Pharmacol 1996;28(3):458-462.
52. Nagaya N, Nishikimi T, Kyotani S, Sakamaki F, Nakada N, Miyatake K, Kangawa K. Pulmonary vasodilator responses to adrenomedullin in patients with pulmonary hypertension. Circulation 1999;100(Suppl I):I-240.
53. Jougasaki M, Wei CM, McKinley LJ, Burnett JC Jr. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 1995;92(3):286-289.
54. Nishikimi T, Saito Y, Kitamura K, Ishimitsu T, Eto T, Kangawa K, et al. Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol 1995;26(6):1424-1431.
55. Jougasaki M, Rodeheffer R, Redfield M, Yamamoto K, Wei CM, McKinley LJ, Burnett JC Jr. Cardiac secretion of adrenomedullin in human heart failure. J Clin Invest 1996;97(10):2370-2376.
56. Kobayashi K, Kitamura K, Hirayama N, Date H, Kashiwagi T, Ikushima I, et al. Increased plasma adrenomedullin in acute myocardial infarction. Am Heart J 1996;131(4):676-680.
57. Øie E, Vinge LE, Yndestad A, Sandherg C, Grøgaard HK, Attramadal H. Induction of a myocardial adrenomedullin signaling system during ischemic heart failure in rats. Circulation 2000;101:415-422.
58. Lainchbury JG, Nicholls MG, Espiner EA, Yandle TG, Lewis LK, Richards AM. Bioactivity and interactions of adrenomedullin and brain natriuretic peptide in patients with heart failure. Hypertension 1999;34(1):70-75.
59. Nishikimi T, Hayashi Y, Iribu G, Takishita S, Kosakai Y, Minamino N, et al. Increased plasma adrenomedullin concentrations during cardiac surgery. Clin Sci 1998;94(6):585-590.
60. Amado JA, Fidalgo I, García-Unzueta MT, Montalbán C, Del Moral I, Pazos F, Diago C. Patients with poor preoperative ejection fraction have a higher plasma response of adrenomedullin in response to open heart surgery. Acta Anaesthesiol Scand 1999;43(8):829-833.
61. Nishio K, Akai Y, Murao Y, Doi N, Ueda S, Tabuse H, et al. Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock. Crit Care Med 1997;25(6):953-957.
62. Yoshibayashi M, Kamiya T, Kitamura K, Saito Y, Kangawa K, Nishikimi T, et al. Plasma levels of adrenomedullin in primary and secondary pulmonary hypertension in patients <20 years of age. Am J Cardiol 1997;79(11):1556-1558.
63. Yamamoto K, Ikeda U, Sekiguchi H, Shimada K. Plasma levels of adrenomedullin in patients with mitral stenosis. Am Heart J 1998;135(3):542-549.
64. Nakamura M, Yoshida H, Makita S, Arakawa N, Niinuma H, Hiramori K. Potent and long-lasting vasodilatory effects of adrenomedullin in humans: comparisons between normal subjects and patients with chronic heart failure. Circulation 1997;95(5):1214-1221.
65. Nagaya N, Nishikimi T, Horio T, Yoshihara F, Kanazawa A, Matsuo H, Kangawa K. Cardiovascular and renal effects of adrenomedullin in rats with heart failure. Am J Physiol 1999;276(1 pt 2):R213-218.
66. Nagaya N, Satoh T, Nishikimi T, Uematsu M, Furuichi S, Sakamaki F, et al. Hemodynamic, renal, and hormone effects of adrenomedullin infusion in patients with congestive heart failure. Circulation 2000;101:498-503.
67. Frishman WH, Weisner M, Somer BG, Deutsch A, Tamirisa P. Natriuretic peptides and other vasoactive peptides: implications for future drug therapy. In: Frishman WH, Sonnenblick EH (eds): Cardiovascular Pharmacotherapeutics. New York: McGraw-Hill, 1997:573-609.